AUTOLUS THERAPEUTICS P
3.2850
27-November-24 09:46:31
15 minutes delayed
Stocks
+0.1900
+6.14%
Today's range
3.1300 - 3.2895
ISIN
N/A
Source
NASDAQ
-
Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
12 Nov 2024 06:00:01 By Nasdaq GlobeNewswire
-
08 Nov 2024 15:23:24 By Nasdaq GlobeNewswire
-
05 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
28 Oct 2024 16:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
19 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
-
27 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
08 Aug 2024 06:00:01 By Nasdaq GlobeNewswire
-
26 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
31 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
17 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
13 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 09:00:00 By Nasdaq GlobeNewswire
-
23 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
02 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Changes to its Board of Directors
01 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
14 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >